Market Research Reports and Industry Reports

Europe Orthobiologics Market by Product (Bone Graft Substitutes, Bone Allografts, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy, Viscosupplementation), by End-User, by Geography - Analysis & Forecast to 2019

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

The European orthobiologics market is estimated to grow at a CAGR of 6.3% from 2014 to 2019. It is the second-largest market in the global orthobiologics market, followed by North America.
 
 Increasing cases of road accidents, as well as rising prevalence of osteoarthritis are propelling the growth of orthobiologics market in this region. The companies operating in this region have been focusing on new product developments, mergers and acquisitions in order to establish their position in this highly competitive and rapidly growing market.
 
 The report has profiled the leading players of this market along with the strategies (new product launches, partnerships, and joint ventures) done adopted by them to sustain and strengthen their position in the European orthobiologics market. The key players in the operating in the European orthobiologics market are Biomet, Inc. (U.S.), Medtronic, Plc. (U.S.), Integra Life Sciences Corporation (U.S.)., Stryker Corporation (U.S.), Zimmer, Inc. (U.S.), DePuy Synthes (U.S.), Tornier, Inc. (Netherlands), Nuvasive, Inc. (U.S.), Exactech, Inc. (U.S.), Globus Medical, Inc. (U.S.), and Wright Medical Technology, Inc. (U.S.).
 
 Reasons to Buy the Report:
 
 From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends, and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments of the orthobiologics market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.
 
 The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market, share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.
 
 The report provides insights on the following pointers:
 
 • Product Analysis and development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the orthobiologics market. Usage pattern/penetration rate (in-depth trend analysis) of products (segment-wise) and purchasing data. Comprehensive coverage of product approvals and product recalls.
 
 • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for orthobiologics across geographies, exploit new clientele base and different pricing policies.
 
 • Market Diversification: Extensive information about new products, untapped geographies, recent developments, and investments decisions in the orthobiologics market. Detailed description regarding the related and unrelated diversification pertaining to this market.
 
 • Competitive Assessment: In-depth assessment of market shares, company share analysis of the key players forecasted till 2019. Develop business strategies and manufacturing capabilities of leading players enhance the bottom line of the companies in the orthobiologics market.
 
 • Product/Brand Perception Analysis: Comprehensive study of customers perception and behavior through our inbuilt social connect tool (digital marketing language) checking the virality and tonality of blogs. 

1 INTRODUCTION 12
 1.1 OBJECTIVES OF THE STUDY 12
 1.2 MARKET SEGMENTATION & COVERAGE 13
 1.3 STAKEHOLDERS 13
 
 2 RESEARCH METHODOLOGY 14
 2.1 INTEGRATED ECOSYSTEM OF ORTHOBIOLOGICS MARKET 15
 2.2 ARRIVING AT THE ORTHOBIOLOGICS MARKET SIZE 15
 2.2.1 TOP-DOWN APPROACH 16
 2.2.2 BOTTOM-UP APPROACH 18
 2.2.3 MACRO INDICATOR-BASED APPROACH 19
 2.3 ASSUMPTIONS 20
 
 3 EXECUTIVE SUMMARY 21
 
 4 MARKET OVERVIEW 23
 4.1 INTRODUCTION 23
 4.2 EUROPEAN ORTHOBIOLOGICS MARKET: COMPARISON WITH PARENT MARKET 24
 4.3 MARKET DRIVERS AND INHIBITORS 25
 4.4 KEY MARKET DYNAMICS 26
 
 5 EUROPEAN ORTHOBIOLOGICS MARKET, BY PRODUCT 27
 5.1 INTRODUCTION 28
 5.2 EUROPEAN ORTHOBIOLOGICS MARKET, PRODUCT COMPARISON WITH ORTHOPEDIC DEVICES MARKET 29
 5.3 EUROPE BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY 30
 5.4 EUROPE BONE ALLOGRAFTS MARKET, BY COUNTRY 31
 5.5 EUROPE BONE GROWTH FACTOR & SPINAL STIMULATION MARKET, BY COUNTRY 32
 5.6 EUROPE STEM CELL THERAPY MARKET, BY COUNTRY 33
 5.7 EUROPE VISCOSUPPLEMENTATION MARKET, BY COUNTRY 34
 
 6 EUROPEAN ORTHOBIOLOGICS MARKET, BY END-USER 36
 6.1 INTRODUCTION 37
 6.2 EUROPE: ORTHOBIOLOGICS MARKET IN HOSPITALS, BY COUNTRY 38
 6.3 EUROPE: ORTHOBIOLOGICS MARKET IN ORTHOPEDIC CLINICS, BY COUNTRY 39
 6.4 EUROPE: ORTHOBIOLOGICS MARKET IN OTHER END-USER MARKET, BY COUNTRY 40
 
 7 EUROPEAN ORTHOBIOLOGICS MARKET, BY COUNTRY 41
 7.1 INTRODUCTION 42
 7.2 GERMANY ORTHOBIOLOGICS MARKET 43
 7.2.1 GERMANY ORTHOBIOLOGICS MARKET, BY PRODUCT 44
 7.2.2 GERMANY ORTHOBIOLOGICS MARKET, BY END-USER 45
 7.3 FRANCE ORTHOBIOLOGICS MARKET 47
 7.3.1 FRANCE ORTHOBIOLOGICS MARKET, BY PRODUCT 47
 7.3.2 FRANCE ORTHOBIOLOGICS MARKET, BY END-USER 49
 7.4 ITALY ORTHOBIOLOGICS MARKET 50
 7.4.1 ITALY ORTHOBIOLOGICS MARKET, BY PRODUCT 51
 7.4.2 ITALY ORTHOBIOLOGICS MARKET, BY END-USER 52
 7.5 SPAIN ORTHOBIOLOGICS MARKET 54
 7.5.1 SPAIN ORTHOBIOLOGICS MARKET, BY PRODUCT 54
 7.5.2 SPAIN ORTHOBIOLOGICS MARKET, BY END-USER 56
 7.6 U.K. ORTHOBIOLOGICS MARKET 57
 7.6.1 U.K.ORTHOBIOLOGICS MARKET, BY PRODUCT 58
 7.6.2 U.K. ORTHOBIOLOGICS MARKET, BY END-USER 59
 
 8 EUROPEAN ORTHOBIOLOGICS MARKET: COMPETITIVE LANDSCAPE 61
 8.1 ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS 61
 8.2 COMPANY PRESENCE IN ORTHOBIOLOGICS MARKET, BY PRODUCT 63
 8.3 MERGERS & ACQUISITIONS 64
 8.4 NEW PRODUCT LAUNCHES 65
 8.5 EXPANSIONS 66
 8.6 AGREEMENTS 67
 8.7 OTHER DEVELOPMENTS 67
 
 9 EUROPEAN ORTHOBIOLOGICS MARKET, BY COMPANY 68
 (Overview, Financials, Products & Services, Strategy, and Developments)*
 9.1 BIOMET, INC. 68
 9.2 MEDTRONIC PLC 72
 9.3 INTEGRA LIFE SCIENCES CORPORATION 75
 9.4 STRYKER CORPORATION 79
 9.5 ZIMMER, INC. 82
 9.6 DEPUY SYNTHES 86
 9.7 TORNIER, INC. 89
 9.8 NUVASIVE, INC. 92
 9.9 EXACTECH, INC. 95
 9.10 GLOBUS MEDICAL INC. 98
 9.11 WRIGHT MEDICAL TECHNOLOGY, INC. 101
 *Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
 
 10 APPENDIX 105
 10.1 CUSTOMIZATION OPTIONS 105
 10.1.1 REGULATORY FRAMEWORK 105
 10.1.2 EPIDEMIOLOGY DATA 105
 10.1.3 SURGEONS/PHYSICIANS PERCEPTION ANALYSIS 105
 10.1.4 IMPACT ANALYSIS 105
 10.2 RELATED REPORTS 106
 10.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 107
 10.3.1 RT SNAPSHOTS 108


List Of Tables

TABLE 1 EUROPEAN ORTHOBIOLOGICS PEER MARKET SIZE, 2014 (USD MN) 17
 TABLE 2 EUROPE: ORTHOBIOLOGICS MARKET: MACRO INDICATOR, BY COUNTRY, 2014 19
 TABLE 3 EUROPE: ORTHOBIOLOGICS MARKET: COMPARISON WITH PARENT MARKET,
 2013 – 2019 (USD MN) 24
 TABLE 4 EUROPEAN ORTHOBIOLOGICS MARKET: DRIVERS AND INHIBITORS 25
 TABLE 5 EUROPEAN ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013 - 2019 (USD MN) 26
 TABLE 6 EUROPE: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013 - 2019 (USD MN) 28
 TABLE 7 EUROPE: ORTHOBIOLOGICS MARKET, PRODUCT COMPARISON WITH PARENT MARKET, 2013–2019 (USD MN) 30
 TABLE 8 EUROPE: BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY, 2013–2019 (USD MN) 31
 TABLE 9 EUROPE: BONE ALLOGRAFTS MARKET, BY COUNTRY, 2013 - 2019 (USD MN) 32
 TABLE 10 EUROPE: BONE GROWTH FACTOR & SPINAL STIMULATION MARKET, BY COUNTRY, 2013 - 2019 (USD MN) 33
 TABLE 11 EUROPE: STEM CELL THERAPY MARKET, BY COUNTRY, 2013 - 2019 (USD MN) 34
 TABLE 12 EUROPE: VISCOSUPPLEMENTATION MARKET, BY COUNTRY, 2013–2019 (USD MN) 35
 TABLE 13 EUROPE: ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2013 - 2019 (USD MN) 37
 TABLE 14 EUROPE: ORTHOBIOLOGICS MARKET IN HOSPITALS, BY COUNTRY,
 2013 - 2019 (USD MN) 38
 TABLE 15 EUROPE: ORTHOBIOLOGICS MARKET IN ORTHOPEDIC CLINICS MARKET SIZE,
 BY COUNTRY, 2013 - 2019 (USD MN) 39
 TABLE 16 EUROPE: OTHER END-USERS MARKET SIZE, BY COUNTRY, 2013 - 2019 (USD MN) 40
 TABLE 17 EUROPE: ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2013 - 2019 (USD MN) 42
 TABLE 18 GERMANY: ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT, 2013-2019 (USD MN) 44
 TABLE 19 GERMANY: ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2013 - 2019 (USD MN) 46
 TABLE 20 FRANCE: ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT, 2013 - 2019 (USD MN) 48
 TABLE 21 FRANCE: ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2013 – 2019 (USD MN) 49
 TABLE 22 ITALY: ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT, 2013 - 2019 (USD MN) 51
 TABLE 23 ITALY ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2013 - 2019 (USD MN) 53
 TABLE 24 SPAIN: ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT, 2013 - 2019 (USD MN) 55
 TABLE 25 SPAIN: ORTHOBIOLOGICS MARKET, BY END-USER, 2013 - 2019 (USD MN) 56
 TABLE 26 U.K.: ORTHOBIOLOGICS MARKET SIZE, BY PRODUCT, 2013 - 2019 (USD MN) 58
 TABLE 27 U.K.: ORTHOBIOLOGICS MARKET, BY END-USER, 2013 - 2019 (USD MN) 60
 TABLE 28 ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS, 2013 (%) 62
 TABLE 29 EUROPEAN ORTHOBIOLOGICS MARKET: MERGERS & ACQUISITIONS 64
 TABLE 30 EUROPEAN ORTHOBIOLOGICS MARKET: NEW PRODUCT LAUNCHES 65
 TABLE 31 EUROPEAN ORTHOBIOLOGICS MARKET: EXPANSIONS 66
 TABLE 32 EUROPEAN ORTHOBIOLOGICS MARKET: AGREEMENTS 67
 TABLE 33 EUROPEAN ORTHOBIOLOGICS MARKET: OTHER DEVELOPMENTS 67
 TABLE 34 BIOMET, INC.: KEY FINANCIALS, 2011 - 2013 (USD MN) 69
 TABLE 35 MEDTRONIC, PLC.: KEY FINANCIALS, 2009 - 2013 (USD MN) 72
 TABLE 36 INTEGRA LIFE SCIENCES CORPORATION: KEY FINANCIALS, 2010 - 2013 (USD MN) 76
 TABLE 37 STRYKER CORPORATION: KEY FINANCIALS, 2009 - 2013 (USD MN) 79
 TABLE 38 ZIMMER, INC.: KEY FINANCIALS, 2009 - 2013 (USD MN) 83
 TABLE 39 DEPUY SYNTHES: KEY FINANCIALS, 2011 - 2013 (USD MN) 87
 TABLE 40 TORNIER, INC.: KEY FINANCIALS, 2009 - 2013 (USD MN) 90
 TABLE 41 NUVASIVE, INC.: KEY FINANCIALS, 2009 – 2013 (USD MN) 92
 TABLE 42 EXACTECH, INC.: KEY FINANCIALS, 2009 -2013 (USD MN) 96
 TABLE 43 GLOBUS MEDICAL, INC.: KEY FINANCIALS, 2009 -2013 (USD MN) 98
 TABLE 44 WRIGHT MEDICAL TECHNOLOGY, INC.: KEY FINANCIALS, 2011 -2013 (USD MN) 102


List Of Figures

FIGURE 1 EUROPEAN ORTHOBIOLOGICS MARKET: SEGMENTATION & COVERAGE 13
 FIGURE 2 ORTHOBIOLOGICS MARKET: INTEGRATED ECOSYSTEM 15
 FIGURE 3 INTEGRATED RESEARCH METHODOLOGY 16
 FIGURE 4 TOP-DOWN APPROACH 17
 FIGURE 5 BOTTOM-UP APPROACH 18
 FIGURE 6 MACRO INDICATOR-BASED APPROACH AGING POPULATION 2014 19
 FIGURE 7 EUROPEAN ORTHOBIOLOGICS MARKET SNAPSHOT, 2014 22
 FIGURE 8 EUROPEAN ORTHOBIOLOGICS PRODUCTS, BY COUNTRY, 2014 (USD MN) 26
 FIGURE 9 EUROPE ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013 - 2019 (USD MN) 28
 FIGURE 10 EUROPE: ORTHOBIOLOGICS MARKET: PRODUCT COMPARISON WITH ORTHOPEDIC DEVICES MARKET, 2013–2019 (USD MN) 29
 FIGURE 11 EUROPE: BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY, 2013–2019 (USD MN) 30
 FIGURE 12 EUROPE: BONE ALLOGRAFTS MARKET, BY COUNTRY, 2013 - 2019 (USD MN) 31
 FIGURE 13 EUROPE: BONE GROWTH FACTOR & SPINAL STIMULATION MARKET, BY COUNTRY, 2013 - 2019 (USD MN) 32
 FIGURE 14 EUROPE: STEM CELL THERAPY MARKET, BY COUNTRY, 2013 - 2019 (USD MN) 33
 FIGURE 15 EUROPE: VISCOSUPPLEMENTATION MARKET, BY COUNTRY, 2013–2019 (USD MN) 34
 FIGURE 16 EUROPE: ORTHOBIOLOGICS MARKET, BY END-USER, 2013 - 2019 (USD MN) 37
 FIGURE 17 EUROPE: ORTHOBIOLOGICS MARKET IN HOSPITALS, BY COUNTRY,
 2013 - 2019 (USD MN) 38
 FIGURE 18 EUROPE: ORTHOBIOLOGICS MARKET IN ORTHOPEDIC CLINICS MARKET, BY COUNTRY, 2013 - 2019 (USD MN) 39
 FIGURE 19 EUROPE: ORTHOBIOLOGICS MARKET IN OTHER END-USER MARKET, BY COUNTRY, 2013 - 2019 (USD MN) 40
 FIGURE 20 EUROPE: ORTHOBIOLOGICS MARKET GROWTH ANALYSIS, BY COUNTRY,
 2014-2019 (USD MN) 42
 FIGURE 21 GERMANY ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%) 43
 FIGURE 22 GERMANY: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 44
 FIGURE 23 GERMANY: ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT 45
 FIGURE 24 GERMANY: ORTHOBIOLOGICS MARKET, BY END-USER, 2013 - 2019 (USD MN) 45
 FIGURE 25 GERMANY ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT 46
 FIGURE 26 FRANCE ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%) 47
 FIGURE 27 FRANCE ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013-2019 (USD MN) 47
 FIGURE 28 FRANCE ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT 48
 FIGURE 29 FRANCE: ORTHOBIOLOGICS MARKET, BY END-USER, 2013 - 2019 (USD MN) 49
 FIGURE 30 FRANCE: ORTHOBIOLOGICS MARKET SHARE, BY END-USER, 2014 & 2019 (%) 50
 FIGURE 31 ITALY ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%) 50
 FIGURE 32 ITALY: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013 - 2019 (USD MN) 51
 FIGURE 33 ITALY: ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT 52
 FIGURE 34 ITALY ORTHOBIOLOGICS MARKET, BY END-USER, 2013 - 2019 (USD MN) 52
 FIGURE 35 ITALY ORTHOBIOLOGICS MARKET: END USER SNAPSHOT 53
 FIGURE 36 SPAIN: ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%) 54
 FIGURE 37 SPAIN: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013 - 2019 (USD MN) 54
 FIGURE 38 SPAIN: ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT 55
 FIGURE 39 SPAIN: ORTHOBIOLOGICS MARKET, BY END-USER, 2013 - 2019 (USD MN) 56
 FIGURE 40 SPAIN: ORTHOBIOLOGICS MARKET: END-USER SNAPSHOT 57
 FIGURE 41 U.K.: ORTHOBIOLOGICS MARKET OVERVIEW, 2014 & 2019 (%) 57
 FIGURE 42 U.K.: ORTHOBIOLOGICS MARKET, BY PRODUCT, 2013 - 2019 (USD MN) 58
 FIGURE 43 U.K.: ORTHOBIOLOGICS MARKET: PRODUCT SNAPSHOT 59
 FIGURE 44 U.K.: ORTHOBIOLOGICS MARKET, BY END-USER, 2013 - 2019 (USD MN) 59
 FIGURE 45 U.K.: ORTHOBIOLOGICS MARKET: END USER SNAPSHOT 60
 FIGURE 46 ORTHOBIOLOGICS MARKET: COMPANY SHARE ANALYSIS, 2013 (%) 61
 FIGURE 47 ORTHOBIOLOGICS: COMPANY PRODUCT COVERAGE, 2013 63
 FIGURE 48 BIOMET, INC.: REVENUE MIX, 2013 (%) 68
 FIGURE 49 CONTRIBUTION OF SPINE, BONE HEALING, & MICROFIXATION SEGMENT TOWARDS COMPANY REVENUES, 2011-2013 (USD MN) 69
 FIGURE 50 MEDTRONIC, PLC. REVENUE MIX, 2013 (%) 72
 FIGURE 51 CONTRIBUTION OF RESTORATIVE THERAPIES GROUP SEGMENT TOWARDS COMPANY REVENUES, 2009-2013 (USD MN) 73
 FIGURE 52 INTEGRA LIFE SCIENCES CORPORATION REVENUE MIX, 2013 (%) 75
 FIGURE 53 CONTRIBUTION OF U.S. SPINE AND OTHER SEGMENT TOWARDS COMPANY REVENUES, 2010-2013 (USD MN) 76
 FIGURE 54 STRYKER CORPORATION REVENUE MIX, 2013 (%) 79
 FIGURE 55 CONTRIBUTION OF NEUROTECHNOLOGY AND SPINE SEGMENT TOWARDS COMPANY REVENUES, 2009-2013 (USD MN) 80
 FIGURE 56 ZIMMER, INC.: REVENUE MIX, 2013 (%) 82
 FIGURE 57 CONTRIBUTION OF SURGICAL AND OTHER SEGMENT TOWARDS COMPANY REVENUES, 2009-2013 (USD MN) 83
 FIGURE 58 DEPUY SYNTHES REVENUE MIX, 2013 (%) 86
 FIGURE 59 TORNIER, INC.: REVENUE MIX 2013 (%) 89
 FIGURE 60 CONTRIBUTION OF EXTREMITIES SEGMENT TOWARDS COMPANY REVENUES,
 2009-2013 (USD MN) 90
 FIGURE 61 NUVASIVE, INC.: REVENUE MIX 2013 (%) 92
 FIGURE 62 CONTRIBUTION OF BIOLOGICS SEGMENT TOWARDS COMPANY REVENUES,
 2009 - 2013 (USD MN) 93
 FIGURE 63 EXACTECH, INC.: REVENUE MIX 2013 (%) 95
 FIGURE 64 CONTRIBUTION OF BIOLOGICS & SPINE SEGMENT TOWARDS COMPANY REVENUES, 2009 - 2013 (USD MN) 96
 FIGURE 65 GLOBUS MEDICAL, INC.: REVENUE MIX 2013 (%) 98
 FIGURE 66 CONTRIBUTION OF DISRUPTIVE TECHNOLOGY SEGMENT TOWARDS COMPANY REVENUES, 2009 - 2013 (USD MN) 99
 FIGURE 67 WRIGHT MEDICAL TECHNOLOGY, INC.: REVENUE MIX 2013 (%) 101
 FIGURE 68 CONTRIBUTION OF BIOLOGICS SEGMENT TOWARDS COMPANY REVENUES,
 2011 - 2013 (USD MN) 102


Europe Laboratory Reagent Dispenser Market Report 2016

Notes:Sales, means the sales volume of Laboratory Reagent DispenserRevenue, means the sales value of Laboratory Reagent DispenserThis report studies sales (consumption) of Laboratory Reagent Dispenser in Europe market, especially in

USD 3900View Report

Europe Glimepiride Market Report 2016

Notes:Sales, means the sales volume of GlimepirideRevenue, means the sales value of GlimepirideThis report studies sales (consumption) of Glimepiride in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux

USD 3900View Report

Europe Garden Sprayers Market Report 2016

Notes:Sales, means the sales volume of Garden SprayersRevenue, means the sales value of Garden SprayersThis report studies sales (consumption) of Garden Sprayers in Europe market, especially in Germany, UK, France,

USD 3900View Report

Global Orthobiologics Market Research Report 2016

2016 Global Orthobiologics Industry Report is a professional and in-depth research report on the worlds major regional market conditions of the Orthobiologics industry, focusing on the main regions (North America,

USD 2850View Report

Global Orthobiologics Market Report 2016

2016 Global Orthobiologics Report is a professional and in-depth research report on The worlds major regional market conditions of The Orthobiologics industry, focusing on The main regions (North America, Europe

USD 2850View Report

Europe Orthobiologics Industry 2016 Market Research Report

The Europe Orthobiologics Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Orthobiologics industry.The report provides a basic overview of the industry

USD 3600View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    $ 2650
  • Multi User Licence    $ 3250
  • Corporate Licence    $ 4505
  • Enterprise Wide Licence    $ 5150
$ 2650

Reports Details

Published Date : Apr 2015
No. of Pages :109
Country :Europe
Category :Healthcare
Publisher :Micro Market Monitor
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment